Authors: Yerly-Motta, V Pavy, JJ Herve, P

Citation: V. Yerly-motta et al., Screening of five specific cell cycle inhibitors using a T cell lymphoma cell line synchrony release assay, BIOTECH HIS, 74(3), 1999, pp. 119-128

Authors: Yerly-Motta, V Pavy, JJ Bosset, SF Arbez-Gindre, F Herve, P

Citation: V. Yerly-motta et al., Validity of PCNA immunostaining in normal and tumor cells: Comparison withKi-67 labeling, J HISTOTECH, 22(4), 1999, pp. 287-293

Authors: Yerly-Motta, V Contassot, E Pavy, JJ Tiberghien, P Herve, P

Citation: V. Yerly-motta et al., Expression of cyclins and cdks throughout murine carcinogenesis, CELL MOL B, 45(8), 1999, pp. 1217-1228

Authors: Wilson, GD Paschoud, N Pavy, JJ Weber, K Weber, P Dubray, B Coucke, PA

Citation: Gd. Wilson et al., Reproducibility of measurements of potential doubling time of tumour cellsin the multicentre National Cancer Institute protocol T92-0045, BR J CANC, 79(2), 1999, pp. 323-332

Authors: Contassot, E Robinet, E Angonin, R Laithier, V Bittencourt, M Pavy, JJ Cahn, JY Herve, P Tiberghien, P

Citation: E. Contassot et al., Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes, BONE MAR TR, 22(11), 1998, pp. 1097-1102